cGMP Controlled Raw Materials | Compliance Webinar

Learn to design the processing of all cGMP controlled raw materials used for the manufacturing of a drug product in the right way.
By: Online Conmpliane Panel LLC
 
FREMONT, Calif. - Oct. 16, 2014 - PRLog -- Instructor: Charity Ogunsanya

Description:


This webinar will allow attendees to gain an understanding on the appropriate way to design the processing of all cGMP Controlled raw materials that are used for the manufacturing of a drug product. The scope of this webinar applies to all cGMP controlled raw materials that are received, requiring testing, release and issuance of specifications. It also applies to the processing of changes and retiring of previously issued controlled raw materials specification within the product manufacturing process. CGMP Raw materials that are used for product manufacturing has to be released for use in the production process. Guidance will be given as to the steps that every drug product manufacturer should follow in order to process all incoming cGMP controlled raw materials, which includes the release for use in the manufacturing of products.

Why Should you Attend:
CGMP raw materials are the most critical ingredient in product manufacturing; hence they must be controlled as stipulated in 21 CFR 110.80 Processes and Controls as well as applicable FDA regulations. Some drug product manufacturers have received FDA 483's and lost several batches of product due to lack of a defined raw material processing that showed acceptability through qualification tests, traceability, consistency and control of the incoming raw materials. Raw material control is therefore a very critical part that ensures drug product quality, purity and potency.

Drug product manufacturers must have a clear understanding in preventing loss of expensively manufactured drug products because of the use of an adulterated raw material through a defined procedure that clearly shows how raw materials are received, stored, labeled, quarantined, tested, qualified, tracked, used, and discarded at the end of expiry. This webinar will provide such guidance as to the process of ensuring that all the steps are followed to avoid producing an adulterated product as defined by the 21 CFR 110.80 Processes and Controls.

Objectives of the Presentation:
This webinar will provide a great resource to Pharmaceutical, Biotechnology and Medical Device Industries personnel that will like to have a clear understanding of the Designing the Receipt, Handling and Processing, Specification, Inventory Tracking, and Qualification of a cGMP Controlled Raw Materials.
Regulatory Requirements for all Incoming cGMP Controlled Raw Materials:

What does the regulation say about raw materials that are received for cGMP use?

Receipt and Storage of cGMP Controlled Raw Materials

Delineation of Raw Materials

Critical
Non-critical

Acceptable Storage of cGMP Controlled Raw Materials

Control of Conditions (Temperature and Humidity Control)
Control of Location (Lock and Key)
Quarantine, Segregation and Labeling Requirements
Testing and Qualification
Approval and Release for use
Disposition and Release for Use Requirements
Dispensing and Traceability (Tracking)
Discarding and Reconciliation

Processing New cGMP Controlled Raw Material Specification

Receiving and Handling of cGMP Controlled Raw Materials
Processing the cGMP Controlled Raw Material Specification
Changing cGMP Controlled Raw Material Specification
Retiring cGMP Controlled Raw Material Specification

Procedure for Raw Material Initial Receipt

When Quality Control Sampling is Required
Processing cGMP Controlled Raw Materials
Assessment and Determination of the Criticality of the cGMP Controlled Raw Materials

Performing the Verification Checks

Testing Requirements for all Incoming cGMP Raw Materials
New and Unqualified cGMP Controlled Raw Materials (Initial Qualification)
Acceptable Testing Programs and Frequency

Test Requirements for Routine and Confirmatory Testing of Qualified cGMP Controlled Raw Materials

Already qualified cGMP Controlled Raw Materials (Subsequent Qualification)
Acceptable Testing Programs and Frequency

Routine and Yearly Confirmatory Testing for Suppliers and Manufacturers of Qualified cGMP Controlled Raw Controlled Materials

Acceptable Testing Programs and Frequency
Review of Supplier Approved Status
Review of Initial Qualification
Review of Quality History
Review of Comparison Criteria
Review of Appropriate Intervals

Evaluation of Suppliers and Manufacturers of cGMP Controlled Raw Materials after Approved Specification Changes

Review of Previous acceptance of affected cGMP controlled raw materials.
Review of the affected change and potential product impact and batch.

Disqualification of cGMP Controlled Raw Materials Test Parameters

When can a cGMP Controlled Raw Material Testing test parameters be disqualified?

Requirements for the Comparison Criteria Used in the Confirmatory Yearly Testing

When comparison criteria can be used in lieu of a full qualification?
How to establish and document comparative analysis in lieu of full controlled material testing.

cGMP Controlled Raw Material Confirmatory Testing Process

Outline of the process for completing the yearly controlled material confirmatory testing.

Issuing and Approving cGMP Controlled Raw Materials Specification

How cGMP Controlled Raw Materials are issued and release?

Processing Failed cGMP Controlled Raw Materials

How to handle a cGMP Controlled Raw Material with a failed result?

Documentation of cGMP Controlled Raw Materials

Documentation Practices and Required Documentation to Satisfy Qualification
Issuance of Specifications

Investigating OOS Associated with Rejected cGMP Controlled Raw Materials

How to investigate a failed cGMP controlled raw material initial and subsequent qualification testing?
Documentation the OOS Investigation of Rejected cGMP Controlled Raw Materials
What to do with Existing cGMP Controlled Raw Materials in Quarantine?

Who can Benefit:
This topic applies to personnel/companies in the Pharmaceutical, Biotechnology, Biololgics, Diagnostics, Cell Therapy and Medical Device Industries. The employees who will benefit most include:
Quality Control Analyst Personnel and Management
Senior Management
Manufacturing Associates Personnel and Management
Facility and Utility Personnel and Management
Quality Assurance Analyst Personnel and Management
Vendors and Suppliers of Pharmaceutical Water Systems and Peripherals
Regulatory Affairs and Personnel Management
Shipping and Receiving Personnel and Management
Materials Handling Personnel and Management
Supplier Quality Personnel and Management
Site Director
Operations Director
Others

 Quick Contact:

---------------------------------

http://www.onlinecompliancepanel.com/ecommerce/webinar/~p...

 Toll free: +1-510-857-5896

 Email: webinar@onlinecompliancepanel.com

 OnlineCompliancePanel LLC,

 38868 Salmon Ter,

 Fremont, CA 94536, USA

 ---------------------------------

Media Contact
David Jonathan Moses
info@onlinecompliancepanel.com
+1-510-857-5896
End
Source:Online Conmpliane Panel LLC
Email:***@onlinecompliancepanel.com
Tags:21 CFR 110.80, Cgmp, Fda Regulations, FDA Documentation Practices, Regulatory Requirements
Industry:Event, Manufacturing
Location:Fremont - California - United States
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
OnlineCompliancePanel News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share